CR20110533A - Compuesto de pirazol - Google Patents

Compuesto de pirazol

Info

Publication number
CR20110533A
CR20110533A CR20110533A CR20110533A CR20110533A CR 20110533 A CR20110533 A CR 20110533A CR 20110533 A CR20110533 A CR 20110533A CR 20110533 A CR20110533 A CR 20110533A CR 20110533 A CR20110533 A CR 20110533A
Authority
CR
Costa Rica
Prior art keywords
compound
pirazol
secretion
tumor
exhibits
Prior art date
Application number
CR20110533A
Other languages
English (en)
Inventor
Nishida Haruyuki
Fujimori Ikuo
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Publication of CR20110533A publication Critical patent/CR20110533A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

La presente invención proporciona un compuesto que tiene una excelente accion supresora de la secreción de un ácido, y que exhibe una actividad anti-tumoral y otras.
CR20110533A 2009-03-26 2011-10-12 Compuesto de pirazol CR20110533A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2009077078 2009-03-26

Publications (1)

Publication Number Publication Date
CR20110533A true CR20110533A (es) 2012-02-13

Family

ID=42781069

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20110533A CR20110533A (es) 2009-03-26 2011-10-12 Compuesto de pirazol

Country Status (25)

Country Link
US (1) US8895588B2 (es)
EP (1) EP2412713B1 (es)
JP (1) JP5552481B2 (es)
KR (1) KR101656906B1 (es)
CN (1) CN102448953B (es)
AU (1) AU2010228220B2 (es)
BR (1) BRPI1009090A2 (es)
CA (1) CA2756086A1 (es)
CL (1) CL2011002351A1 (es)
CO (1) CO6460700A2 (es)
CR (1) CR20110533A (es)
DO (1) DOP2011000296A (es)
EA (1) EA019853B1 (es)
EC (1) ECSP11011419A (es)
GE (1) GEP20156222B (es)
IL (1) IL215235A (es)
MA (1) MA33214B1 (es)
MX (1) MX2011009943A (es)
NZ (1) NZ595890A (es)
PE (1) PE20120618A1 (es)
SG (1) SG174476A1 (es)
TN (1) TN2011000474A1 (es)
UA (1) UA107457C2 (es)
WO (1) WO2010110378A1 (es)
ZA (1) ZA201107435B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR091567A1 (es) 2012-06-27 2015-02-11 Takeda Pharmaceutical Preparacion liquida, metodo, kit de inyeccion
TWI732158B (zh) 2012-09-27 2021-07-01 美商雅瑞塔那醫療公司 使用食慾喪失控制化合物之組合物及方法
ES2902795T3 (es) 2015-01-28 2022-03-29 Elanco Animal Health Incorporated Composición para uso crónico como compuesto para aumentar de peso
CN105067814A (zh) * 2015-07-24 2015-11-18 中国科学院成都生物研究所 解旋酶水解atp活性测定方法
MX2022016515A (es) * 2020-06-17 2023-01-30 Ildong Pharmaceutical Co Ltd Nuevo inhibidor de la secrecion de acido y uso del mismo.

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3285991A (en) 1963-03-26 1966-11-15 Union Carbide Corp Polyepoxides cured with the reaction product of a dihydroxydiphenylsul-fone, an amine, and an aldehyde
US4847289A (en) 1987-06-08 1989-07-11 Merck & Co., Inc. Thiophene sulfonamide antiglaucoma agents
CN1071924A (zh) 1991-10-29 1993-05-12 纳幕尔杜邦公司 除草的三唑羧酸酰胺
RU2157368C2 (ru) 1994-09-26 2000-10-10 Сионоги Энд Ко., Лтд. Производные имидазола и фармацевтическая композиция на их основе
JPH0948778A (ja) 1995-08-04 1997-02-18 Sagami Chem Res Center ２−置換−３−アルコキシ−５−（ピロール−２−イル）フラン誘導体
JP4533466B2 (ja) 1995-11-06 2010-09-01 ユニバーシティ オブ ピッツバーグ 蛋白質イソプレニルトランスフェラーゼの阻害剤
CN1246847A (zh) 1996-12-23 2000-03-08 杜邦药品公司 作为Xa因子抑制剂的含氮杂芳族化合物
WO1999042461A1 (en) 1998-02-23 1999-08-26 Warner-Lambert Company Substituted quinoxaline derivatives as interleukin-8 receptor antagonists
WO2004012659A2 (en) 2002-08-01 2004-02-12 Nitromed, Inc. Nitrosated proton pump inhibitors, compositions and methods of use
ATE410161T1 (de) 2003-05-02 2008-10-15 Elan Pharm Inc 4-bromo-5-(2-chloro-benzoylamino)-1h-pyrazol-3- carbonsäureamid-derivate und verwandte verbindungen als bradykinin b1 rezeptor antagonisten zur behandlung von entzündlichen erkrankungen
JP4716996B2 (ja) 2003-05-26 2011-07-06 武田薬品工業株式会社 スルホピロール
JP4836788B2 (ja) 2003-07-23 2011-12-14 エグゼリクシス， インコーポレイテッド 未分化リンパ腫キナーゼ変調因子及びその使用法
WO2006036024A1 (ja) 2004-09-30 2006-04-06 Takeda Pharmaceutical Company Limited プロトンポンプ阻害薬
AU2006285641A1 (en) * 2005-08-30 2007-03-08 Takeda Pharmaceutical Company Limited 1-heterocyclylsulfonyl, 2-aminomethyl, 5- (hetero-) aryl substituted 1-h-pyrrole derivatives as acid secretion inhibitors
WO2007114338A1 (ja) * 2006-03-31 2007-10-11 Takeda Pharmaceutical Company Limited 酸分泌抑制薬
US8933105B2 (en) * 2007-02-28 2015-01-13 Takeda Pharmaceutical Company Limited Pyrrole compounds
JP2009077078A (ja) 2007-09-19 2009-04-09 Brother Ind Ltd 位置検出システム
WO2009041705A2 (en) * 2007-09-28 2009-04-02 Takeda Pharmaceutical Company Limited 5-membered heterocyclic compounds as proton pump inhibitors
WO2009041447A1 (ja) 2007-09-28 2009-04-02 Takeda Pharmaceutical Company Limited ５員複素環化合物
PE20091846A1 (es) 2008-05-19 2009-12-16 Plexxikon Inc DERIVADOS DE PIRROLO[2,3-d]-PIRIMIDINA COMO MODULADORES DE CINASAS
KR20110036044A (ko) 2008-07-18 2011-04-06 다케다 파머수티컬 컴패니 리미티드 벤즈아제핀 유도체들 및 히스타민 ｈ3 길항제로서 이들의 용도

Also Published As

Publication number Publication date
UA107457C2 (uk) 2015-01-12
SG174476A1 (en) 2011-10-28
EP2412713B1 (en) 2016-11-30
NZ595890A (en) 2013-09-27
AU2010228220B2 (en) 2015-05-21
CN102448953A (zh) 2012-05-09
US20120095057A1 (en) 2012-04-19
PE20120618A1 (es) 2012-06-05
CL2011002351A1 (es) 2012-07-13
US8895588B2 (en) 2014-11-25
GEP20156222B (en) 2015-01-26
DOP2011000296A (es) 2011-10-15
BRPI1009090A2 (pt) 2016-03-01
JP5552481B2 (ja) 2014-07-16
CA2756086A1 (en) 2010-09-30
AU2010228220A1 (en) 2011-11-17
JPWO2010110378A1 (ja) 2012-10-04
MX2011009943A (es) 2011-10-06
EP2412713A4 (en) 2014-04-02
TN2011000474A1 (en) 2013-03-27
IL215235A (en) 2014-07-31
WO2010110378A1 (ja) 2010-09-30
AU2010228220A2 (en) 2011-11-24
EA201171168A1 (ru) 2012-05-30
ECSP11011419A (es) 2011-11-30
EA019853B1 (ru) 2014-06-30
MA33214B1 (fr) 2012-04-02
EP2412713A1 (en) 2012-02-01
ZA201107435B (en) 2012-08-29
KR20110130483A (ko) 2011-12-05
KR101656906B1 (ko) 2016-09-12
CO6460700A2 (es) 2012-06-15
CN102448953B (zh) 2014-05-07
IL215235A0 (en) 2011-12-29

Similar Documents

Publication Publication Date Title
MX338884B (es) Composiciones y metodos que comprenden variantes de proteasa.
UY34763A (es) Inhibidores de la agregación plaquetaria
MX345909B (es) Anticuerpos anti-fgfr3 y métodos que los utilizan.
UY34342A (es) ?derivados de pirrolopirimidina y purina?.
MX2011011925A (es) Anticuerpos triespecificos o tetraespecificos.
MX340555B (es) Anticuerpos contra il-18r1 y usos de los mismos.
ES2530730T3 (es) Complejo hidrohalogenuro-agomelatina y preparación del mismo
UY34536A (es) Nucleósidos sustituidos, nucleótidos y análogos de los mismos
MX368288B (es) Una combinación de anticuerpos anti-cd38 y melfalán para usarse en el tratamiento de mieloma múltiple.
UY34767A (es) Inhibidores cíclicos del enlace éter de dgat1
MX2012011829A (es) Anticuerpos de anti-poliubiquitina y metodos de uso.
MY161868A (en) Anti-bv8 antibodies and uses thereof
CR20140296A (es) Dispositivo de Reducción activa de interferencia-ruido y un método relacionado con el mismo
GT201300041A (es) Composicion fungicida sinergista
EA201400940A1 (ru) Способ получения медетомидина
CR20110533A (es) Compuesto de pirazol
MX2016007988A (es) Nuevo compuesto para el tratamiento de hipoglucemia severa.
PH12016501182A1 (en) Novel compound for treatment of severe hypoglycemia
MX2016007984A (es) Nuevo compuesto para el tratamiento de hipoglucemia severa.
RU2010119316A (ru) Поли - n, n- диаллиламиноэтановая кислота
RU2009122188A (ru) Средство, повышающее противоопухолевый эффект метотрексата
RU2009100631A (ru) 2-гидрокси-4-оксо-4-фенил-2-бутеноат бензотиазолиламмония, обладающий гипогликемической активностью
UY33207A (es) Métodos de preparación de tiazolidinas
RU2011116802A (ru) 1-(1-адамантил)-4-нитрозопиразолы
CL2009001553S1 (es) Mesa.